Predictive Value of Neuromuscular Ultrasound of Cranial Nerves in Guillain-Barré Syndrome
NCT06200454 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 102
Last updated 2024-01-11
Summary
1. Sensitivity and specificity of cranial neuromuscular US to detect the prognosis of Guillain Barre Syndrome
2. Correlation of US values with motor, respiratory and autonomic complications of Guillain Barre Syndrome
Conditions
- Guillain-Barre Syndrome
Interventions
- DEVICE
-
neuromuscular ultrasound of cranial nerves
neuromuscular ultrasound of cranial nerves.
Sponsors & Collaborators
-
Assiut University
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2024-01-08
- Primary Completion
- 2025-01-08
- Completion
- 2025-06-08
More Related Trials
-
IVIG Versus Plasmapheresis in the Treatment of Guillian Barrie Syndrome Patients
NCT05104762 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Living With Guillain-Barré Syndrome as Children.
NCT06940908 ·Status: RECRUITING
-
Efficacy of Intravenous Gamma Globulin on Guillain-Barre Syndrome
NCT04303962 ·Status: UNKNOWN
-
Efficacy and Safety Study of GB-0998 for Guillain-Barré Syndrome
NCT02342184 ·Status: COMPLETED ·Phase: PHASE3
-
Multispectral Optoacoustic Imaging for the Detection of Inflammation and Damage of Peripheral Nerves in Guillain-Barré Syndrome and Chronic Inflammatory Demyelinating Polyneuropathy
NCT07121985 ·Status: NOT_YET_RECRUITING
-
Comparison of the Efficacy and Safety of Immunoadsorption and Intravenous Immunoglobulin for Guillain-Barre Syndrome
NCT05114941 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Mini-pool Intravenous Immunoglobulin (MP-IVIG) in Guillain-Barré Syndrome
NCT04550611 ·Status: UNKNOWN ·Phase: NA
-
Predictive Factors of Long Term Outcome in MMN
NCT04015934 ·Status: COMPLETED
-
Immunoadsorption Versus Plasma Exchange for Treatment of Guillain-Barré Syndrome (GBS)
NCT04871035 ·Status: RECRUITING
-
Inhibition of Complement Activation (Eculizumab) in Guillain-Barre Syndrome Study
NCT02029378 ·Status: UNKNOWN ·Phase: PHASE2
-
Efficacy and Safety of ANX005 in Subjects With Guillain-Barré Syndrome
NCT04701164 ·Status: COMPLETED ·Phase: PHASE3
-
Randomized Study of Plasmapheresis or Human Immunoglobulin Infusion in Childhood Guillain-Barre Syndrome
NCT00004833 ·Status: TERMINATED ·Phase: NA
-
Upper Limb Robot-Assisted Therapy in Patients with Guillain-Barré Syndrome
NCT06620198 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Efficacy and Safety of Vaccination Against COVID-19 in Neuromuscular Patients
NCT05311904 ·Status: COMPLETED
-
Phase III Clinical Trial of NPB-01 in Patients With Guillain-Barré Syndrome
NCT02221271 ·Status: COMPLETED ·Phase: PHASE3
-
Biomarkers in Polyradiculoneuropathies
NCT04249752 ·Status: UNKNOWN
-
Change of Nerve Conduction Properties in IVIg Dependent Neuropathies
NCT01655394 ·Status: UNKNOWN
-
IVIg Treatment-Related Fluctuations in CIDP Patients Using Daily Grip Strength Measurements
NCT02414490 ·Status: COMPLETED
-
Peripherical Neuromuscular Electrical Stimulation in Systemic Autoimmune Myopathies
NCT03751644 ·Status: COMPLETED ·Phase: NA
-
Identification of Celiac Ganglia
NCT01010360 ·Status: COMPLETED
-
Stellate Ganglion Block in Longstanding Facial Nerve Palsy Patients
NCT06742255 ·Status: NOT_YET_RECRUITING
-
Safety and Efficacy of Intravenous Immune Globulin in Treating Spinocerebellar Ataxia
NCT01350440 ·Status: COMPLETED ·Phase: PHASE2
-
RWE-based Treatment Patterns and Outcomes in CIDP
NCT05940922 ·Status: UNKNOWN
-
Evaluation of the Diagnostic Contributions of Nerve Ultrasound in Chronic Inflammatory Demyelinating Polyneuropathy Associating Systemic Diseases (CIDP Echo-nerf)
NCT05257733 ·Status: WITHDRAWN
-
JET-GBS - Japanese Eculizumab Trial for GBS
NCT02493725 ·Status: COMPLETED ·Phase: PHASE2